DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Neuronal SignalingNeuronal Signaling
  5. /FAAHFAAH
  6. /PF 04457845PF 04457845
Chemical structure of CAS 1020315-31-4

PF 04457845

CAS No.1020315-31-4
MDL No.MFCD18782721
MFC23H20F3N5O2
MW455.40
InChI KeyBATCTBJIJJEPHM-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1020315-31-4
Product NamePF 04457845

Biological Targets

FAAH

Associated Conditions

sleep·Tourette syndrome·Chronic pain·liver disease·cannabis dependence·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Persistent proteomic changes in glutamatergic and GABAergic signaling in the amygdala of adolescent rats exposed to chlorpyrifos as juveniles.

Neurotoxicology • Vol. 85 • 2021
PMID: 34058248PMC: PMC8276847DOI: 10.1016/j.neuro.2021.05.012

Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474.

Science (New York, N.Y.) • Vol. 356, Issue 6342 • 2017
PMID: 28596366PMC: PMC5641481DOI: 10.1126/science.aaf7497

Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats.

Psychopharmacology • Vol. 233, Issue 10 • 2016
PMID: 26558620PMC: PMC4846548DOI: 10.1007/s00213-015-4140-6

Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences • Vol. 52 • 2014
PMID: 24275607DOI: 10.1016/j.ejps.2013.11.012

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact